KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Pension (2016 - 2026)

NovoCure's Pension history spans 13 years, with the latest figure at $4.7 million for Q1 2026.

  • On a quarterly basis, Pension fell 18.67% to $4.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.7 million, a 18.67% decrease, with the full-year FY2025 number at $3.9 million, down 43.26% from a year prior.
  • Pension hit $4.7 million in Q1 2026 for NovoCure, up from $3.9 million in the prior quarter.
  • Over the last five years, Pension for NVCR hit a ceiling of $8.3 million in Q4 2023 and a floor of $3.0 million in Q1 2022.
  • Historically, Pension has averaged $5.5 million across 5 years, with a median of $5.4 million in 2023.
  • Biggest five-year swings in Pension: skyrocketed 101.28% in 2022 and later tumbled 43.26% in 2025.
  • Tracing NVCR's Pension over 5 years: stood at $4.4 million in 2022, then surged by 87.51% to $8.3 million in 2023, then decreased by 15.96% to $6.9 million in 2024, then plummeted by 43.26% to $3.9 million in 2025, then increased by 19.12% to $4.7 million in 2026.
  • Business Quant data shows Pension for NVCR at $4.7 million in Q1 2026, $3.9 million in Q4 2025, and $6.5 million in Q3 2025.